Respiratorymuscle trainingwith enzyme replacement therapy improves muscle strength in late - onset Pompe disease

被引:16
作者
Mitja, Jevnikar [1 ]
Metka, Kodric [1 ]
Fabiana, Cantarutti [1 ]
Cifaldi, Rossella [1 ]
Longo, Cinzia [1 ]
Rossana, Della Porta [1 ]
Bruno, Bembi [2 ]
Marco, Confalonieri [1 ]
机构
[1] Univ Hosp Cattinara, Dept Pneumol, Trieste, Italy
[2] Univ Hosp S Maria Misericordia, Rare Dis Reg Ctr, Udine, Italy
来源
MOLECULAR GENETICS AND METABOLISM REPORTS | 2015年 / 5卷
关键词
Pompe disease; Late-onset type II glycogenosis; Respiratory muscles; Muscle training; Enzyme replacement therapy;
D O I
10.1016/j.ymgmr.2015.09.007
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Pompe disease is an autosomal recessive metabolic disorder caused by the deficiency of the lysosomal enzyme acida-glucosidase. This deficiency leads to glycogen accumulation in the lysosomes of muscle tissue causing progressive muscular weakness particularly of the respiratory system. Enzyme replacement therapy (ERT) has demonstrated efficacy in slowing down disease progression in infants. Despite the large number of studies describing the effects of physical training in juvenile and adult late onset Pompe disease (LOPD). There are very few reports that analyze the benefits of respiratory muscle rehabilitation or training. Methods: The effectiveness of respiratory muscle training was investigated using a specific appliance with adjustable resistance (Threshold). The primary endpoint was effect on respiratory muscular strength by measurements of MIP and MEP. Eight late-onset Pompe patients (aged 13 to 58 years; 4 female, 4 male) with respiratory muscle deficiency on functional respiratory tests were studied. All patients received ERT at the dosage of 20 mg/kg/every 2 weeks and underwent training with Threshold at specified pressures for 24 months. Results: A significant increase in MIP was observed during the follow-up of 24 month: 39.6 cm H2O (+ 25.0%) at month 3; 39.5 cm H2O (+ 24.9%) at month 6; 39.1 cm H2O (+ 23.7%) at month 9; 37.3 cm H2O (+ 18.2%) at month 12; and 37.3 cmH(2)O (+ 17.8%) atmonth 24. MedianMEP values also showed a significant increase during the first 9 months: 29.8 cm H2O, (+ 14.3%) at month 3; 31.0 cm H2O (+ 18.6) at month 6; and 29.5 cm H2O (+ 12.9) at month 9. MEP was then shown to be decreased at months 12 and 24; median MEP was 27.2 cm H2O (+ 4.3%) at 12 months and 26.6 cmH(2)O (+ 1.9%) at 24 months. The FVC remain stable throughout the study. Conclusion: An increase in respiratory muscular strength was demonstrated with Threshold training when used in combination with ERT. (C) 2015 The Authors. Published by Elsevier Inc.
引用
收藏
页码:67 / 71
页数:5
相关论文
共 23 条
  • [1] Bembi B., 2010, J INHERIT METAB DIS
  • [2] Case L. E., 2006, GENET MED
  • [3] Physical therapy management of Pompe disease
    Case, Laura Elizabeth
    Kishnani, Priya Sunil
    [J]. GENETICS IN MEDICINE, 2006, 8 (05) : 318 - 327
  • [4] INSPIRATIonAL - INSPIRAtory muscle training in amyotrophic lateral sclerosis
    Cheah, Benjamin C.
    Boland, Robert A.
    Brodaty, Nina E.
    Zoing, Margie C.
    Jeffery, Sandra E.
    McKenzie, David K.
    Kiernan, Matthew C.
    [J]. AMYOTROPHIC LATERAL SCLEROSIS, 2009, 10 (5-6): : 384 - 392
  • [5] Consensus treatment recommendations for late-onset Pompe disease
    Cupler, Edward J.
    Berger, Kenneth I.
    Leshner, Robert T.
    Wolfe, Gil I.
    Han, Jay J.
    Barohn, Richard J.
    Kissel, John T.
    [J]. MUSCLE & NERVE, 2012, 45 (03) : 319 - 333
  • [6] Inspiratory muscular activation during threshold® therapy in elderly healthy and patients with COPD
    de Andrade, AD
    Silva, TNS
    Vasconcelos, H
    Marcelino, M
    Rodrigues-Machado, MG
    Galindo, VC
    Moraes, NH
    Marinho, PEM
    Amorim, CF
    [J]. JOURNAL OF ELECTROMYOGRAPHY AND KINESIOLOGY, 2005, 15 (06) : 631 - 639
  • [7] Fowler WM, 2002, AM J PHYS MED REHAB, V81, pS187, DOI 10.1097/00002060-200211001-00019
  • [8] Increased inspiratory and expiratory muscle strength following respiratory muscle strength training (RMST) in two patients with late-onset Pompe disease
    Jones, Harrison N.
    Moss, Tronda
    Edwards, Laurie
    Kishnani, Priya S.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2011, 104 (03) : 417 - 420
  • [9] Pompe disease diagnosis and management guideline
    Kishnani, Priya S.
    Steiner, Robert D.
    Bali, Deeksha
    Berger, Kenneth
    Byrne, Barry J.
    Case, Laura
    Crowley, John F.
    Downs, Steven
    Howell, R. Rodney
    Kravitz, Richard M.
    Mackey, Joanne
    Marsden, Deborah
    Martins, Anna Maria
    Millington, David S.
    Nicolino, Marc
    O'Grady, Given
    Patterson, Marc C.
    Rapoport, David M.
    Slonim, Alfred
    Spencer, Carolyn T.
    Tifft, Cynthia J.
    Watson, Michael S.
    [J]. GENETICS IN MEDICINE, 2006, 8 (05) : 267 - 288
  • [10] Chinese hamster ovary cell-derived recombinant human acid α-glucosidase in infantile-onset Pompe disease
    Kishnani, Priya Sunil
    Nicolino, Marc
    Voit, Thomas
    Rogers, R. Curtis
    Tsai, Anne Chun-Hui
    Waterson, John
    Herman, Gail E.
    Amalfitano, Andreas
    Thurberg, Beth L.
    Richards, Susan
    Davidson, Mark
    Corzo, Deyanira
    Chen, Y. T.
    [J]. JOURNAL OF PEDIATRICS, 2006, 149 (01) : 89 - 97